If you're seeing this message, that means
JavaScript has been disabled on your browser
, please
enable JS
to make this app work.
No tags found
Companies
No companies found
Advanced Search
Newsfeed
Alerts
Saved Lists
Sign Up for Free
Login
Source: FinanzNachrichten
BIOLAB: QUANTUM GENOMICS: Quantum Genomics and Biolab Sanus Pharmaceutical Enter into Exclusive Licensing and Collaboration Agreement for Firibastat in Latin America
Biolab Sanus Pharmaceutical to receive an exclusive license to develop and commercialize firibastat for the treatment of arterial hypertension in Latin America Quantum Genomics (Euronext Growth - ...
Read full article »
BIOLAB's Competitors
|
BIOLAB's News
|
BIOLAB's Financials
Follow
Followers on Owler
514
Est. Annual Revenue
$1.0-5.0B
Est. Employees
1.0-5.0K
CEO
Update CEO
CEO Approval Rating
- -/100
Read more
See Biolab Pharma company profile »